• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体结合放射性药物动力学系统的拟合优度和局部可识别性。

Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.

作者信息

Vera D R, Scheibe P O, Krohn K A, Trudeau W L, Stadalnik R C

机构信息

Department of Radiology, University of California, Davis, Medical Center, Sacramento 95817.

出版信息

IEEE Trans Biomed Eng. 1992 Apr;39(4):356-67. doi: 10.1109/10.126608.

DOI:10.1109/10.126608
PMID:1592401
Abstract

A four-state nonlinear model describing a radiopharmacokinetic system for a hepatic receptor-binding radiopharmaceutical, [99mTc]-galactosyl-neoglycoalbumin (TcNGA), was tested for goodness-of-fit and local identifiability using scanning data from nine healthy subjects and seven patients with severe liver disease. Based on standard deviations of liver and heart imaging data at equilibria as a measure of observational error, the reduced chi-square ranged from 0.5 to 2.6. Values above 1.2 occurred when the subject moved during the 30 min study. Relative standard errors for each parameter were: TcNGA-receptor forward binding rate constant kb, 13-54%; extra-hepatic plasma volume Ve, 0.8-15.0%; hepatic plasma volume Vh, 0.2-6.5%; hepatic plasma flow F, 54----greater than 1000%; and receptor concentration [R]o, 0.3-13%. The highest standard errors occurred when the amount of TcNGA injected exceeded the total amount of receptor. Therefore, when TcNGA functional imaging was performed without excess patient motion and receptor saturation, the kinetic model provided data fits of low systematic error and yielded high precision estimates of receptor concentration and forward binding rate constant. In summary, optimal performance of the kinetic model occurred when the amount of injected TcNGA resulted in the nonlinear operation of the pharmacokinetic system.

摘要

一个描述肝脏受体结合放射性药物[99mTc] - 半乳糖基新糖白蛋白(TcNGA)放射性药代动力学系统的四态非线性模型,使用来自9名健康受试者和7名严重肝病患者的扫描数据进行了拟合优度和局部可识别性测试。以平衡时肝脏和心脏成像数据的标准差作为观测误差的度量,约化卡方值范围为0.5至2.6。当受试者在30分钟研究期间移动时,会出现高于1.2的值。每个参数的相对标准误差为:TcNGA - 受体正向结合速率常数kb,13 - 54%;肝外血浆体积Ve,0.8 - 15.0%;肝血浆体积Vh,0.2 - 6.5%;肝血浆流量F,54%至大于1000%;以及受体浓度[R]o,0.3 - 13%。当注入的TcNGA量超过受体总量时,标准误差最高。因此,当在没有过多患者移动和受体饱和的情况下进行TcNGA功能成像时,动力学模型提供了低系统误差的数据拟合,并对受体浓度和正向结合速率常数产生了高精度估计。总之,当注入的TcNGA量导致药代动力学系统非线性运行时,动力学模型表现最佳。

相似文献

1
Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.受体结合放射性药物动力学系统的拟合优度和局部可识别性。
IEEE Trans Biomed Eng. 1992 Apr;39(4):356-67. doi: 10.1109/10.126608.
2
Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.具有已知不确定性测量参数的受体结合放射性药代动力学系统的局部可识别性。
IEEE Trans Biomed Eng. 1994 Sep;41(9):891-7. doi: 10.1109/10.312097.
3
Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.通过锝-99m-半乳糖基新糖白蛋白的放射性药代动力学建模测量受体浓度和正向结合速率常数。
J Nucl Med. 1991 Jun;32(6):1169-76.
4
Diagnostic performance of a receptor-binding radiopharmacokinetic model.一种受体结合放射性药物动力学模型的诊断性能
J Nucl Med. 1996 Jan;37(1):160-4.
5
Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.[99mTc]半乳糖基新糖白蛋白的肝脏摄取对受体数量敏感。
Int J Rad Appl Instrum B. 1991;18(7):663-6. doi: 10.1016/0883-2897(91)90003-4.
6
Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.一种受体结合放射性药物的动力学敏感性:锝-99m半乳糖基新糖白蛋白
J Nucl Med. 1989 Sep;30(9):1519-30.
7
Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.用于体内受体生物化学估计的放射性药物动力学数据的自动制备。
J Nucl Med. 1996 Nov;37(11):1896-902.
8
[Pharmacokinetic studies on 99mTc-NGA in human].99mTc-NGA在人体的药代动力学研究
Hua Xi Yi Ke Da Xue Xue Bao. 1993 Sep;24(3):268-70.
9
Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.通过[99mTc]半乳糖基新糖白蛋白测量有功能的肝细胞质量。
Dig Dis Sci. 1993 Dec;38(12):2183-8. doi: 10.1007/BF01299893.
10
Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.通过一种肝细胞特异性配体:99mTc-半乳糖基-新糖白蛋白来测定急性病毒性肝炎中的肝功能。
Hepatology. 1992 Apr;15(4):593-8. doi: 10.1002/hep.1840150407.

引用本文的文献

1
Selection of weighting factors for quantification of PET radioligand binding using simplified reference tissue models with noisy input functions.使用带有噪声输入函数的简化参比组织模型对 PET 配体结合进行定量分析时加权因子的选择。
Phys Med Biol. 2012 Feb 7;57(3):609-29. doi: 10.1088/0031-9155/57/3/609. Epub 2012 Jan 12.
2
A visualization-based analysis method for multiparameter models of capillary tissue-exchange.一种基于可视化的毛细血管组织交换多参数模型分析方法。
Ann Biomed Eng. 1996 Jan-Feb;24(1):124-38. doi: 10.1007/BF02771001.
3
Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
通过[99mTc]半乳糖基新糖白蛋白测量有功能的肝细胞质量。
Dig Dis Sci. 1993 Dec;38(12):2183-8. doi: 10.1007/BF01299893.